LETTER FROM THE EDITOR
Founders Narender Panjwani & Thomas Masterson
Publisher & Managing Director Narender Panjwani narender @ ghapac . com
Chief Executive Officer and President Varun Panjwani varun @ ghapac . com
Editor Gabriele Bettinazzi gabriele @ ghapac . com
Editorial Director ( Aesthetics ), Branding and Communication Manager Drishti Panjwani drishti @ ghapac . com
Copy editor Martin Murphy
General Manager , Asia Pacific SK WONG sk @ ghapac . com
Business Development & Account Manager Rhainna rhainna @ ghapac . com
Events Manager Ms Ally Kim Design N oel de G uzman / Ar tmazing !
Creative / Production Director Harivarmaa Perumal ( Hust ) hust @ ghapac . com
Canada Office Anjika Sabhani anjika @ ghapac . com
Kishor Sabhani kishor @ ghapac . com 900 Rice Road , Edmonton T6R 1A2 , Alberta Canada , Tel . 1-780-4999011
Dubai Office Anil Dadlani Anil @ leouae . com 2207 Regal Tower , Business Bay , PO BOX 126161 , Dubai , UAE Tel . 97150-2149000
India Office Surbhi Pandit Surbhi @ ghapac . com A-27 , South Extension , Part 2 , New Delhi , 110049
Malaysia Office GHT Malaysia Sdn Bhd Level 18 , WeWork , Plaza Equatorial , Jalan Sultan Ismail , 50250 Kuala Lumpur
Singapore Office Narender Panjwani Narender @ ghapac . com 15 Scotts Road , # 04-08 Thong Teck Building ( 15 Scotts ), Room No . 12 , Singapore 228218
This issue covers one of the most dreadful diseases afflicting humans — Alzheimer ’ s . Its ability to disrupt cognitive functions , like memory , chips away at our personal identities and the most intimate aspects of who we commonly think we are .
Current treatments are still barely effective and offer only modest benefits . Despite the lack of medical progress , however , trained caregivers can make a real difference in patients ’ lives if they ’ re properly trained and supported . The hope is that , over the next 10 years , improved therapies currently under research will make the disease treatable in a way similar to how we now treat cancer and heart disease .
We also feature an interview with a UK rehabilitation specialist who is starting to see the impacts of long COVID beginning to wane , as most patients are now suffering from less severe symptoms and are showing much better chances of recovering over time compared to the early days of the pandemic . The condition , however , remains poorly understood and still sickens a minority of patients for the long term , meaning that more research is needed to develop better treatment options .
In medical news , we highlight a promising study of lupus patients who went into remission after receiving CAR T cell therapy , an advanced technique already proven to treat cancers like leukaemia and lymphoma . It involves engineering the patient ’ s immune cells , or T cells , in the lab to recognise and destroy other cells that are causing health problems . If the improvements continue over the long term , the therapy could offer a potential cure for a disease that wreaks havoc on millions of peoples ’ lives globally , especially women .
Gabriele Bettinazzi Editor gabriele @ ghapac . com
Available across Asia , the Middle East and North America
Visit our website : www . GlobalHealthAsiaPacific . com to download the digital version
Printed by : Times Offset ( Malaysia ) Sdn Bhd ( 194695-W )
Global Health Asia-Pacific is a publication of HealthFYX Pte Ltd . 15 Scotts Road , # 04-08 Thong Teck Building ( 15 Scotts ), Room No . 12 , Singapore 228218
For circulation enquiries please contact narender @ ghapac . com or call + 65 8126 2615
Global Health Asia-Pacific is a licensed trademark of HealthFYX Pte Ltd .
All rights reserved . No part of this publication may be reproduced or transmitted in any form or by any means , electronic or mechanical , including photocopy , recording or any information storage and retrieval system , without the written permission of the Publisher .
2 SEPTEMBER 2022 GlobalHealthAsiaPacific . com